Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New robot aims to speed up kidney and prostate surgeries

NCT ID NCT06849271

Disease control Sponsor: Rob Surgical Systems S.L. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new robotic system (Bitrack) for kidney and prostate surgeries in 27 adults. The goal was to see if the system could perform surgeries as fast as or faster than current robotic methods. The study looked at surgery time and followed patients for 30 days after surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

27 people

The number who actually took part.

Started

Jan 2025

Finished

Nov 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Adult subjects between 18 and 90 years old who have provided written informed consent prior to any clinical investigation related procedures. 2. Subjects who have been scheduled for a laparoscopic Radical/simple Nephrectomy surgery, laparoscopic Partial Nephrectomy or laparoscopic Radical Prostatectomy following the surgeon criteria. 3. Ability and willingness to comply with all study requirements to be evaluated for each study visit. Exclusion Criteria: 1. Pregnant or breastfeeding women at the time of the surgery. 2. Subjects with severe concomitant illness that, at PrincipaI investigator´s discretion, increases risk of therapeutic interventions or that have been submitted to multiple prior surgeries. 3. Subjects admitted to the hospital due to an emergency situation. 4. Subjects with untreated active infection. 5. Subject with known allergy to some of the device components (i.e., stainless steel, etc.) 6. Subjects not suitable to undergo Minimally Invasive Surgery (MIS)/ Minimally Invasive Robotic Surgery (MIRS), according to medical criteria. 7. Subjects with life expectancy inferior to 3 months. 8. Subjects with a BMI (Body Mass Index) ≥ 40 9. Subjects with any contraindication for the use of the ROB-Bitrack System and the ESE/NESE instruments, as specified in the Instructions For Use. 10. Subjects with abuses of active substances or with uncontrolled psychiatric disorders. 11. Subjects with severe cardiopulmonary or coronary artery disease, bleeding disorders or that have been submitted to multiple prior operations. 12. Subjects scheduled for surgeries intended to be in direct contact with the heart, the central circulatory system or the central nervous system. 13. Inability to adhere to study-related procedures. 14. Subjects who participate in another trial which may affect the outcome data on this study or the ability to complete the follow up requirements

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Nephrectomy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Nephrectomy Prostatectomy

Contacts and locations

Locations

  • Hospital Clinic de Barcelona

    Barcelona, Spain, 08036, Spain

  • Hospital General de Granollers

    Granollers, Spain, 08402, Spain

  • Hospital Universitari de Vic

    Vic, Spain, 08500, Spain

  • Hospital de Mataró

    Mataró, Spain, 08304, Spain

  • Hospital del Mar

    Barcelona, Spain, 08003, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.